|
| quote: | Originally posted by djSlain
hi again. let's rumble |
Sure champ.
Please refute these studies:
http://norml.com/index.cfm?Group_ID=5732
| quote: | Pot Compound Reduces Agitation, Improves Appetite In Alzheimer's Patients, Study Says
August 21, 2003 - Chicago, IL, USA
Chicago, IL: A synthetic version of the marijuana compound tetrahydrocannabinol (THC) reduced agitation and stimulated weight gain in patients with Alzheimer's disease, according to clinical trial data presented this week at the annual meeting of the International Psychogeriatric Association.
Researchers presented data from a retrospective review of 48 patients residing in a dementia unit of an assisted living facility or nursing home. Patients in the trial received up to 10 mg of synthetic THC daily for one month. Thirty-one patients (66 percent) experienced significant improvement in agitation, and 33 (69 percent) experienced observable functional improvements as a result of the treatment, scientists found.
In addition, all 48 volunteers gained weight during the trial. Weight loss, a common symptom associated with Alzheimer's disease, is a predictive factor of mortality.
No adverse side effects to the THC treatment were reported.
In May, speakers at the annual meeting of the American Geriatrics Society presented similar findings from a nine-patient clinical trial. A 1997 trial of 12 Alzheimer patients also found that THC significantly decreased negative feelings and induced weight gain. |
http://norml.com/index.cfm?Group_ID=5761
| quote: | Cannabinoids Modulate Epileptic Seizures, Study Says
October 2, 2003 - Richmond, VA, USA
Richmond, VA: Administration of delta-9-tetrahydrocannabinol (THC), the primary psychoactive ingredient in marijuana, "completely abolished" spontaneous seizures in an animal model of epilepsy, according to findings published this week in the Journal of Pharmacology and Experimental Therapeutics.
Authors also noted that endogenous cannabinoids, marijuana-like substances produced naturally by the human body, appeared to play a role in regulating seizure duration and frequency.
"These data indicate not only the anticonvulsant activity of exogenously applied cannabinoids, but also suggest that endogenous cannabinoid[s] ... modulate seizure termination and duration," researchers concluded.
The study is the first to examine the role of marijuana and the endogenous cannabinoid system in an animal model of epilepsy characterized by spontaneous, recurrent seizures.
Previous animal studies have demonstrated that cannabinoids possess anticonvulsant activity; however, a handful of human trials examining the effects of the cannabinoid cannabidiol (CBD) on epileptic-induced seizures have yielded mixed results. A recent trial in England of cannabis extracts on an in vitro form of epilepsy found that extracts performed more effectively than THC alone in treating symptoms of the disease. |
___________________
http://www.discoboomer.com/forums/
|
